Company Filing History:
1 out of 5,448 
1 out of 3,097 
Years Active: 2019
Title: Kristina Y Aguilera: Innovator in Therapeutic Agents
Introduction
Kristina Y Aguilera is a prominent inventor based in Dallas, TX (US). She has made significant contributions to the field of therapeutic agents, particularly through her innovative research and patent work. Her dedication to advancing medical science has led to the development of new compounds that hold promise for treating various health conditions.
Latest Patents
Kristina holds a patent for "Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof." This patent includes compounds of formula (I), their pharmaceutically acceptable salts, and stereoisomers. These compounds are designed to effectively inhibit the enzymatic activity of discoidin domain receptor 1. They can be utilized as new therapeutic agents for preventing and treating conditions such as inflammation, liver fibrosis, kidney fibrosis, lung fibrosis, skin scars, atherosclerosis, and cancer.
Career Highlights
Throughout her career, Kristina has worked with esteemed institutions, including the University of Texas System and the Chinese Academy of Sciences. Her work has been instrumental in advancing research in her field and has garnered attention for its potential impact on healthcare.
Collaborations
Kristina has collaborated with notable colleagues, including Rolf A Brekken and Ke Ding. These partnerships have enriched her research and contributed to the development of her innovative therapeutic agents.
Conclusion
Kristina Y Aguilera's contributions to the field of therapeutic agents exemplify her commitment to innovation and medical advancement. Her work continues to inspire future research and development in the treatment of various diseases.